Wietrzyk Joanna, Chodyński Michał, Fitak Hanna, Wojdat Elzbieta, Kutner Andrzej, Opolski Adam
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław bPharmaceutical Research Institute, Warsaw, Poland.
Anticancer Drugs. 2007 Apr;18(4):447-57. doi: 10.1097/CAD.0b013e3280143166.
Analogs of 1,25-dihydroxyvitamin D3 with a reversed configuration at C-1 or C-24 and E or Z geometry of the double bond at C-22 in the side chain or at C-5 in the triene system were examined for their antiproliferative activity in vitro against a spectrum of various human cancer cell lines. The analogs coded PRI-2201 (calcipotriol), PRI-2202 and PRI-2205, such as calcitriol and tacalcitol (used as a referential agents), revealed antiproliferative activity against human HL-60, HL-60/MX2, MCF-7, T47D, SCC-25 and mouse WEHI-3 cancer cell lines. The toxicity studies in vivo showed that PRI-2202 and PRI-2205 are less toxic than referential agents. Even at total doses of 2.5-5.0 mg/kg distributed during 5 successive days, no changes in body weight were observed. Calcitriol and tacalcitol showed toxicity in the same protocol at 100 times lower doses. Calcipotriol was lethal to all mice after administration of a total dose of 5.0 mg/kg. The analog PRI-2205 appeared to be more active in mouse Levis lung cancer tumor growth inhibition than calcitriol, calcipotriol or PRI-2202. This analog did not reveal calcemic activity at doses which inhibit tumor growth in vivo nor at higher doses.
对1,25 - 二羟基维生素D3的类似物进行了研究,这些类似物在C - 1或C - 24处具有反向构型,并且侧链中C - 22处或三烯系统中C - 5处的双键具有E或Z几何构型,考察了它们在体外对一系列不同人类癌细胞系的抗增殖活性。编码为PRI - 2201(卡泊三醇)、PRI - 2202和PRI - 2205的类似物,如骨化三醇和他卡西醇(用作参考剂),显示出对人HL - 60、HL - 60/MX2、MCF - 7、T47D、SCC - 25和小鼠WEHI - 3癌细胞系的抗增殖活性。体内毒性研究表明,PRI - 2202和PRI - 2205的毒性低于参考剂。即使在连续5天内给予总剂量为2.5 - 5.0 mg/kg的情况下,也未观察到体重变化。骨化三醇和他卡西醇在相同方案中以低100倍的剂量显示出毒性。给予总剂量5.0 mg/kg后,卡泊三醇对所有小鼠均具有致死性。类似物PRI - 2205在抑制小鼠Lewis肺癌肿瘤生长方面似乎比骨化三醇、卡泊三醇或PRI - 2202更具活性。该类似物在体内抑制肿瘤生长的剂量下以及更高剂量下均未显示出血钙活性。